Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000570368

Apexbio Technology LLC AG-1295-5MG
SDP

Catalog No. 5000570368
Encompass_Preferred

AG-1295 (CAS No 71897-07-9) is a prominent tyrosine kinase inhibitor predominantly used in cancer research Originating from studies focusing on receptor-mediated cellular pathways AG-1295 specifically targets platelet-derived growth factor receptors (PDGFR) which play a crucial role in cell proliferation and angiogenesis By inhibiting these pathways it effectively disrupts the signaling cascade vital for tumor growth In vitro AG-1295 exhibits activity in the nanomolar to low micromolar range making it a potent agent for various experimental settings Its applications span across cell models including fibroblasts and smooth muscle cells as well as animal studies aimed at understanding disease mechanisms and testing new therapeutic strategies It is also incorporated in drug screening processes to identify potential oncological treatments Experimental concentrations typically depend on the specific research design

Catalog No. 50-005-70368 Supplier Apexbio Technology LLC Supplier No. C54655
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AG-1295 (CAS No 71897-07-9) is a prominent tyrosine kinase inhibitor predominantly used in cancer research Originating from studies focusing on receptor-mediated cellular pathways AG-1295 specifically targets platelet-derived growth factor receptors (PDGFR) which play a crucial role in cell proliferation and angiogenesis By inhibiting these pathways it effectively disrupts the signaling cascade vital for tumor growth In vitro AG-1295 exhibits activity in the nanomolar to low micromolar range making it a potent agent for various experimental settings Its applications span across cell models including fibroblasts and smooth muscle cells as well as animal studies aimed at understanding disease mechanisms and testing new therapeutic strategies It is also incorporated in drug screening processes to identify potential oncological treatments Experimental concentrations typically depend on the specific research design

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.